Immunotech Laboratories, Inc. and Immunotech Laboratories, BG. recently announced the successful completion of Phase I and Phase II field trials in Bulgaria of the company's HIV/AIDS and Hepatitis C virus treatment and have begun negotiations for sites in Macedonia and Serbia for Phase III testing on human patients. The clinical test are being conducted through Immunotech Laboratories, BG (IMMB-BG) Since 2013 IMMB-BG hired and funded the Clinical Research Organization to conduct all preclinical and monitoring phase III clinical studies.

The product for the Bulgarian study was produce under GMP conditions by a US. Contract Manufacturing Facility. The successful completion of Phase III clinical study testing would enable Immunotech Laboratories to move forward using the Phase I, II, & III clinical trial results, for the FDA application pertaining to legal use of the treatment for HIV/AIDS and Hepatitis 'C' patients in the USA.